IL131126A - Compositions for reducing the incidence of necrotizing enterocolitis and the preparation thereof - Google Patents
Compositions for reducing the incidence of necrotizing enterocolitis and the preparation thereofInfo
- Publication number
- IL131126A IL131126A IL13112698A IL13112698A IL131126A IL 131126 A IL131126 A IL 131126A IL 13112698 A IL13112698 A IL 13112698A IL 13112698 A IL13112698 A IL 13112698A IL 131126 A IL131126 A IL 131126A
- Authority
- IL
- Israel
- Prior art keywords
- incidence
- compositions
- reducing
- necrotizing enterocolitis
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Fats And Perfumes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL15049098A IL150490A0 (en) | 1997-02-21 | 1998-02-19 | A process for the production of an enteral formula containing arachidonic acid and/or docosahexaenoic acid in the form of phospholipids and formula obtained by same |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80470097A | 1997-02-21 | 1997-02-21 | |
US82531497A | 1997-03-28 | 1997-03-28 | |
US08/943,576 US6080787A (en) | 1997-02-21 | 1997-10-03 | Methods for reducing the incidence of necrotizing enterocolitis |
PCT/US1998/003235 WO1998036745A2 (en) | 1997-02-21 | 1998-02-19 | Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis |
Publications (2)
Publication Number | Publication Date |
---|---|
IL131126A0 IL131126A0 (en) | 2001-01-28 |
IL131126A true IL131126A (en) | 2003-04-10 |
Family
ID=27420004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13112698A IL131126A (en) | 1997-02-21 | 1998-02-19 | Compositions for reducing the incidence of necrotizing enterocolitis and the preparation thereof |
Country Status (24)
Country | Link |
---|---|
US (1) | US6306908B1 (xx) |
EP (1) | EP1039892B1 (xx) |
JP (1) | JP2001516343A (xx) |
CN (1) | CN1200701C (xx) |
AT (1) | ATE265207T1 (xx) |
AU (1) | AU732903B2 (xx) |
BR (1) | BR9807443A (xx) |
CA (1) | CA2281706C (xx) |
DE (1) | DE69823548T2 (xx) |
DK (1) | DK1039892T3 (xx) |
ES (1) | ES2219871T3 (xx) |
HK (1) | HK1034033A1 (xx) |
HU (1) | HUP0300236A3 (xx) |
ID (1) | ID22744A (xx) |
IL (1) | IL131126A (xx) |
NO (1) | NO994052L (xx) |
NZ (1) | NZ337039A (xx) |
PL (1) | PL343902A1 (xx) |
PT (1) | PT1039892E (xx) |
RU (1) | RU2199317C2 (xx) |
SK (1) | SK112399A3 (xx) |
TR (1) | TR199902023T2 (xx) |
TW (1) | TWI230607B (xx) |
WO (1) | WO1998036745A2 (xx) |
Families Citing this family (106)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL121165A0 (en) * | 1997-06-26 | 1997-11-20 | Yissum Res Dev Co | Pharmaceutical compositions containing carboxylic acids and derivatives thereof |
US6180671B1 (en) | 1998-03-10 | 2001-01-30 | Beth Israel Deaconess Medical Center, Inc. | Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected |
DE19836339B4 (de) | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
US20090274660A1 (en) * | 1999-08-17 | 2009-11-05 | Immunopath Profile, Inc. | Pluripotent therapeutic compositions and uses thereof |
US6596302B2 (en) * | 2000-04-13 | 2003-07-22 | Abbott Laboratories | Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof |
PT1542670E (pt) * | 2002-09-24 | 2013-07-11 | Suntory Holdings Ltd | Composição com efeitos na prevenção do declínio, melhoramento ou aumento de respostas normais de aptidões cognitivas de uma pessoa saudável |
US7323206B1 (en) | 2003-03-04 | 2008-01-29 | B. Braun Medical Inc. | Reagents and methods for all-in-one total parenteral nutrition for neonates and infants |
GB0311081D0 (en) * | 2003-05-14 | 2003-06-18 | Btg Internat Limted | Treatment of neurodegenerative conditions |
PL1638414T3 (pl) * | 2003-06-23 | 2009-12-31 | Nestec Sa | Mleko modyfikowane niemowlęce lub następne |
WO2005000040A1 (en) * | 2003-06-24 | 2005-01-06 | University Of Kansas Medical Center | Infant formula |
WO2005018632A1 (en) * | 2003-08-18 | 2005-03-03 | Btg International Limited | Treatment of neurodegenerative conditions |
EP1597978A1 (en) | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
US8252769B2 (en) | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
EP1721611A1 (en) * | 2005-04-21 | 2006-11-15 | N.V. Nutricia | Nutritional supplement with oligosaccharides for a category of HIV patients |
DE602005017389D1 (de) * | 2004-06-22 | 2009-12-10 | Nutricia Nv | Verbesserung der barriereintegrität bei hiv-patienten mit hilfe von fettsäuren |
US7862808B2 (en) | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
EP1656839A1 (en) | 2004-11-11 | 2006-05-17 | N.V. Nutricia | Nutrition containing lipid blend |
GB0425932D0 (en) * | 2004-11-25 | 2004-12-29 | Btg Int Ltd | Structured phospholipids |
GB0504362D0 (en) * | 2005-03-02 | 2005-04-06 | Btg Int Ltd | Cytokine modulators |
GB0504333D0 (en) * | 2005-03-02 | 2005-04-06 | Btg Int Ltd | Treatment of cytokine dysregulation |
US7303745B2 (en) | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
US20060233762A1 (en) * | 2005-04-15 | 2006-10-19 | Mcmahon Robert J | Method for treating or preventing systemic inflammation in formula-fed infants |
WO2006112716A2 (en) * | 2005-04-21 | 2006-10-26 | N.V. Nutricia | Nutritional supplement for hiv patients |
EP1888081B1 (en) | 2005-05-23 | 2016-12-28 | Massachusetts Institute of Technology | Compositions containing pufa and methods of use thereof |
JP2007063219A (ja) * | 2005-09-01 | 2007-03-15 | Juntendo | 新生児壊死性腸炎疾患予防剤 |
US20070166354A1 (en) | 2005-10-26 | 2007-07-19 | Bridget Barrett-Reis | Method of reducing the risk of retinopathy of prematurity in preterm infants |
US7829126B2 (en) | 2005-10-26 | 2010-11-09 | Abbott Laboratories | Infant formulas containing docosahexaenoic acid and lutein |
WO2007059431A1 (en) | 2005-11-14 | 2007-05-24 | The Trustees Of Columbia University In The City Of New York | Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs |
WO2014160989A2 (en) | 2013-03-28 | 2014-10-02 | The Trustees Of Columbia University In The City Of New York | Reperfusion with omega-3 glycerides promotes donor organ protection for transplantation |
RU2444210C2 (ru) * | 2005-12-23 | 2012-03-10 | Н.В. Нютрисиа | Питательные композиции для младенцев, предназначенные для предупреждения ожирения |
US20080003330A1 (en) * | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Infant formulas for early brain development |
US20080003329A1 (en) * | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Enriched infant formulas |
US7867542B2 (en) * | 2006-11-02 | 2011-01-11 | Ach Food Companies, Inc. | Non-flammable release composition |
WO2009039101A1 (en) | 2007-09-17 | 2009-03-26 | Cornell University | Branched chain fatty acids for prevention or treatment of gastrointestinal disorders |
DK2207429T4 (en) † | 2007-10-09 | 2017-04-10 | Enzymotec Ltd | Lipid Compositions for the Treatment of Gastrointestinal Diseases |
UY31410A1 (es) * | 2007-10-30 | 2009-05-29 | Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado | |
MX2010004820A (es) | 2007-11-01 | 2010-08-10 | Enzymotec Ltd | Mezcla lipidica para nutricion infantil. |
US8361534B2 (en) * | 2007-12-20 | 2013-01-29 | Abbott Laboratories | Stable nutritional powder |
WO2009085388A2 (en) | 2007-12-20 | 2009-07-09 | Abbott Laboratories | Stable nutritional powder |
EP2100897A1 (en) * | 2008-01-30 | 2009-09-16 | BNLfood Investments SARL | Lecithin based composition and its use in food |
WO2009096772A1 (en) * | 2008-02-01 | 2009-08-06 | N.V. Nutricia | Composition for stimulating natural killer cell activity |
US9737213B1 (en) * | 2009-03-24 | 2017-08-22 | Vioptix, Inc. | Using an oximeter probe to detect intestinal ischemia |
US9480670B2 (en) * | 2009-04-01 | 2016-11-01 | Nestec S.A. | Reduction of risk of obesity |
TW201112967A (en) | 2009-09-16 | 2011-04-16 | Abbott Lab | Dryblended nutritional powders |
TW201121431A (en) | 2009-12-01 | 2011-07-01 | Abbott Lab | Soy protein-based nutritional formula with superior stability |
TWI492744B (zh) * | 2009-12-04 | 2015-07-21 | Abbott Lab | 使用類胡蘿蔔素調節早產兒發炎症之方法 |
MX2012006640A (es) * | 2009-12-08 | 2012-06-25 | Nestec Sa | Formula infantil con probioticos y componentes de la membrana del globulo graso de la leche. |
NZ601141A (en) * | 2010-01-19 | 2014-07-25 | Abbott Lab | Nutritional formulas containing synbiotics |
CA2785523A1 (en) | 2010-01-29 | 2011-08-04 | Abbott Laboratories | Aseptically packaged nutritional liquids comprising hmb |
US9693577B2 (en) | 2010-01-29 | 2017-07-04 | Abbott Laboratories | Method of preparing a nutritional powder comprising spray dried HMB |
EP2528459B1 (en) | 2010-01-29 | 2014-06-11 | Abbott Laboratories | Nutritional emulsions comprising calcium hmb |
TWI526161B (zh) | 2010-06-10 | 2016-03-21 | 亞培公司 | 包含鈣hmb及可溶性蛋白質之實質上透明營養液 |
EP2397038A1 (en) | 2010-06-21 | 2011-12-21 | Abbott Laboratories | Early programming of brain function through soy protein feeding |
WO2012009426A1 (en) | 2010-07-13 | 2012-01-19 | Abbott Laboratories | High tolerance infant formula including hydrolyzed protein |
EP2422629A1 (en) | 2010-08-23 | 2012-02-29 | Abbott Laboratories | Methods for enhancing cognition and/or memory using maltodextrins |
CN103153095B (zh) | 2010-08-24 | 2015-07-22 | 雅培制药有限公司 | 具有改良感官特性的营养产品 |
WO2012027287A1 (en) | 2010-08-24 | 2012-03-01 | Abbott Laboratories | Nutritional products including pea protein hydrolysates |
DK2498628T3 (da) | 2010-12-29 | 2014-06-23 | Abbott Lab | Produkter til at formindske forekomsten af nekrotiserende enterocolitis, kolik og korttarmsyndrom hos et spædbarn, en tumling eller et barn |
CA2822495C (en) | 2010-12-31 | 2020-12-22 | Abbott Laboratories | Methods of using human milk oligosaccharides for improving airway respiratory health |
EP2658547A1 (en) | 2010-12-31 | 2013-11-06 | Abbott Laboratories | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
CA2822664C (en) | 2010-12-31 | 2021-07-20 | Abbott Laboratories | Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof |
WO2012092155A1 (en) | 2010-12-31 | 2012-07-05 | Abbott Laboratories | Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota |
ES2804258T3 (es) | 2010-12-31 | 2021-02-05 | Abbott Lab | Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios |
MX355424B (es) | 2010-12-31 | 2018-04-18 | Abbott Lab | Oligosacáridos de leche humana para modular la inflamación. |
NZ612472A (en) | 2010-12-31 | 2015-02-27 | Abbott Lab | Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection |
MX355780B (es) | 2010-12-31 | 2018-04-30 | Abbott Lab | Fórmula pediátrica sintética para estimular células nerviosas entéricas en el tracto gastrointestinal. |
WO2013012989A2 (en) | 2011-07-19 | 2013-01-24 | The Trustees Of Columbia University In The City Of New York | Method and system for production of hydrogen and carbon monoxide |
BR112014001472A2 (pt) | 2011-07-22 | 2017-02-21 | Abbott Lab | galactooligossacarídeos para prevenir lesões e / ou promover a cicatrização do trato gastrointestinal |
BR112014004772A2 (pt) | 2011-08-29 | 2017-03-21 | Abbott Lab | oligossacarídeos do leite humano para evitar danos e/ou promover a cura do trato gastrointestinal |
WO2013101591A2 (en) | 2011-12-29 | 2013-07-04 | Abbott Laboratories | Methods for reducing microbial contamination of dryblended powdered nutritional compositions |
WO2013101516A1 (en) | 2011-12-29 | 2013-07-04 | Abbott Laboratories | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using extracted genomic dna |
EP2830712A1 (en) | 2012-03-27 | 2015-02-04 | Abbott Laboratories | Methods for modulating cell-mediated immunity using human milk oligosaccharides |
WO2013170189A1 (en) | 2012-05-11 | 2013-11-14 | Abbott Laboratories | Combination of beta - hydroxy - beta - methylbutyrate and beta - alanine for increasing muscle blood flow |
EP3704957A1 (en) | 2012-09-14 | 2020-09-09 | Abbott Laboratories | Methods for increasing brain functionality using 2-fucosyl-lactose |
EP2708145B1 (en) | 2012-09-14 | 2016-05-04 | Abbott Laboratories | Nutritional compositions for use in methods for modulating corticosterone levels in psychologically stressed individuals |
EP2708146A1 (en) | 2012-09-17 | 2014-03-19 | Abbott Laboratories, Inc. | Nutritional composition for pregnant women with a beneficial glucose and insulin profile |
WO2014078544A1 (en) | 2012-11-14 | 2014-05-22 | Abbott Laboratories | Compositions and methods for improving the long term safety of powdered infant formulas |
WO2014099904A1 (en) | 2012-12-17 | 2014-06-26 | Abbott Laboratories | Methods for enhancing motor function, enhancing functional status and mitigating muscle weakness in a subject |
EP2745705A1 (en) | 2012-12-18 | 2014-06-25 | Abbott Laboratories | Nutritional use of human milk oligosaccharides |
BR112015014420A2 (pt) | 2012-12-18 | 2017-07-11 | Abbott Lab | oligossacarídeos do leite humano para melhorar sintomas de estresse |
WO2014100022A1 (en) | 2012-12-18 | 2014-06-26 | Abbott Laboratories | Dietary oligosaccharides to enhance learning and memory |
CN110679948A (zh) | 2012-12-20 | 2020-01-14 | 雅培制药有限公司 | 使用人乳寡糖用于调节炎症的营养制剂 |
EP2745708A1 (en) | 2012-12-24 | 2014-06-25 | Abbott Laboratories, Inc. | Antidepressant effect of ß-hydroxy-ß-methylbutyrate |
JP2016510603A (ja) | 2013-03-12 | 2016-04-11 | アボット・ラボラトリーズAbbott Laboratories | 多機能型粘度調整剤を含む組成物 |
MX2015013000A (es) | 2013-03-15 | 2015-12-01 | Abbott Lab | Metodos de mantenimiento y mejora de la funcion muscular. |
BR112015022757A2 (pt) | 2013-03-15 | 2017-07-18 | Abbott Lab | composições nutricionais que incluem beta-hidróxi-beta-metilbutirato de cálcio, fosfopeptídeo de caseína, e proteína |
TW201524372A (zh) | 2013-06-10 | 2015-07-01 | Abbott Lab | 用於提升認知能力的方法及組合物 |
WO2015048646A1 (en) | 2013-09-30 | 2015-04-02 | Abbott Laboratories | Protein powder |
JP2016536010A (ja) | 2013-10-11 | 2016-11-24 | アボット・ラボラトリーズAbbott Laboratories | 有益なグルコースおよびインスリンプロファイルを有する妊婦用の栄養組成物 |
CN103558296B (zh) * | 2013-10-18 | 2015-03-04 | 中国农业大学 | 一种基于脂肪酸检测的动物源性饲料原料鉴别方法 |
CN104623637A (zh) | 2013-11-07 | 2015-05-20 | 健能隆医药技术(上海)有限公司 | Il-22二聚体在制备静脉注射药物中的应用 |
WO2015077233A1 (en) | 2013-11-19 | 2015-05-28 | Abbott Laboratories | Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides |
EP2888950A1 (en) | 2013-12-24 | 2015-07-01 | Abbott Laboratories | Methods for treating, preventing, or reducing neuroinflammation or cognitive impairment |
WO2015105981A2 (en) | 2014-01-09 | 2015-07-16 | Abbott Laboratories | Conditional essentiality of hmb |
WO2015157098A1 (en) | 2014-04-08 | 2015-10-15 | Abbott Laboratories | Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides |
DE102015101273A1 (de) * | 2015-01-29 | 2016-08-04 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Prophylaxe und Behandlung von frühgeburtlichkeitsassoziierten Entwicklungsstörungen |
WO2017181143A1 (en) | 2016-04-15 | 2017-10-19 | Generon (Shanghai) Corporation, Ltd. | Use of il-22 in treating necrotizing enterocolitis |
RU2665947C1 (ru) * | 2017-07-13 | 2018-09-05 | Атикат Магомедхановна Герейханова | Способ лечения некротического энтероколита |
WO2020247225A1 (en) | 2019-06-07 | 2020-12-10 | Abbott Laboratories | Nutritional ingredient with flow and antifoam properties |
MX2022012509A (es) | 2020-04-06 | 2022-11-07 | Abbott Lab | Formulaciones nutricionales para modular citocinas inducidas por la respiracion. |
CN112137998A (zh) * | 2020-10-10 | 2020-12-29 | 上海交通大学医学院附属新华医院 | 一种活性成分在制备防治坏死性小肠结肠炎药物中的应用 |
WO2022177965A1 (en) | 2021-02-16 | 2022-08-25 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin |
WO2022226311A1 (en) | 2021-04-23 | 2022-10-27 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and a designed lipid component for improving lung function |
WO2022266058A1 (en) | 2021-06-14 | 2022-12-22 | Abbott Laboratories | Methods and compositions for treating gas |
WO2023159093A1 (en) | 2022-02-16 | 2023-08-24 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin |
WO2024064327A1 (en) | 2022-09-22 | 2024-03-28 | Abbott Laboratories | Human milk oligosaccharides for enhancing blood-brain barrier function |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0092121B1 (en) | 1982-04-12 | 1987-12-16 | Board Of Regents, The University Of Texas System | Methods and compositions for treating gastro-intestinal ulcer diesease |
US4670285A (en) | 1982-08-06 | 1987-06-02 | The University Of Toronto Innovations Foundation | Infant formula |
US4784861A (en) | 1986-11-24 | 1988-11-15 | Cca Industries, Inc. | Weight-control formulation |
US5043329A (en) | 1987-02-17 | 1991-08-27 | Board Of Regents, University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
US4918063A (en) * | 1987-02-17 | 1990-04-17 | Board Of Regents, The University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
US4950656A (en) | 1987-02-17 | 1990-08-21 | Board Of Regents, The University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
US5032585A (en) | 1987-02-17 | 1991-07-16 | Board Of Regents, The University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy |
US5000975A (en) | 1988-12-29 | 1991-03-19 | American Home Products Corporation | Randomized palm oil fat composition for infant formulas |
US5116819A (en) * | 1989-05-05 | 1992-05-26 | Clintec Nutrition Co. | Enteral diet for patients with pulmonary disease |
US5658767A (en) | 1991-01-24 | 1997-08-19 | Martek Corporation | Arachidonic acid and methods for the production and use thereof |
KR100321543B1 (ko) | 1991-01-24 | 2002-09-12 | 마르텍 코포레이션 | 미생물-기원오일혼합물및이의용도 |
WO1993020717A2 (en) * | 1992-04-13 | 1993-10-28 | Research Corporation Technologies, Inc. | Reducing gastrointestinal irritation in infant nutrition |
DE4407939A1 (de) * | 1993-03-15 | 1994-09-22 | Sueddeutsche Kalkstickstoff | Verfahren zur Herstellung von fett- und cholesterinreduzierten pulverförmigen Produkten auf Eibasis |
FR2721481B1 (fr) * | 1994-06-27 | 1996-09-06 | Inst Rech Biolog Sa | Nouvelles compositions diététiques à base de phospholipides et leur utilisation comme complément nutritionnel. |
DK0784437T3 (da) | 1994-10-05 | 1999-04-19 | Milupa Gmbh & Co Kg | Phospholipidholdig fedtblanding med LCP-fedtsyrer |
JPH09201A (ja) * | 1995-06-23 | 1997-01-07 | Akikuni Yakida | 炎症性腸疾患用食品 |
US5917068A (en) | 1995-12-29 | 1999-06-29 | Eastman Chemical Company | Polyunsaturated fatty acid and fatty acid ester mixtures free of sterols and phosphorus compounds |
US5790138A (en) | 1996-01-16 | 1998-08-04 | Monolithic System Technology, Inc. | Method and structure for improving display data bandwidth in a unified memory architecture system |
-
1998
- 1998-02-19 HU HU0300236A patent/HUP0300236A3/hu unknown
- 1998-02-19 IL IL13112698A patent/IL131126A/xx not_active IP Right Cessation
- 1998-02-19 RU RU99119892/14A patent/RU2199317C2/ru not_active IP Right Cessation
- 1998-02-19 AU AU61769/98A patent/AU732903B2/en not_active Ceased
- 1998-02-19 ES ES98906580T patent/ES2219871T3/es not_active Expired - Lifetime
- 1998-02-19 JP JP53687198A patent/JP2001516343A/ja active Pending
- 1998-02-19 DK DK98906580T patent/DK1039892T3/da active
- 1998-02-19 WO PCT/US1998/003235 patent/WO1998036745A2/en active Search and Examination
- 1998-02-19 NZ NZ337039A patent/NZ337039A/en unknown
- 1998-02-19 PL PL98343902A patent/PL343902A1/xx unknown
- 1998-02-19 ID IDW990897A patent/ID22744A/id unknown
- 1998-02-19 CA CA002281706A patent/CA2281706C/en not_active Expired - Fee Related
- 1998-02-19 TR TR1999/02023T patent/TR199902023T2/xx unknown
- 1998-02-19 DE DE69823548T patent/DE69823548T2/de not_active Revoked
- 1998-02-19 BR BR9807443-1A patent/BR9807443A/pt not_active IP Right Cessation
- 1998-02-19 EP EP98906580A patent/EP1039892B1/en not_active Revoked
- 1998-02-19 AT AT98906580T patent/ATE265207T1/de not_active IP Right Cessation
- 1998-02-19 SK SK1123-99A patent/SK112399A3/sk unknown
- 1998-02-19 CN CNB988043726A patent/CN1200701C/zh not_active Expired - Fee Related
- 1998-02-19 PT PT98906580T patent/PT1039892E/pt unknown
- 1998-04-03 TW TW087102492A patent/TWI230607B/zh not_active IP Right Cessation
-
1999
- 1999-08-23 NO NO994052A patent/NO994052L/no not_active Application Discontinuation
-
2000
- 2000-05-12 US US09/570,299 patent/US6306908B1/en not_active Expired - Lifetime
-
2001
- 2001-03-29 HK HK01102292A patent/HK1034033A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1998036745A2 (en) | 1998-08-27 |
ES2219871T3 (es) | 2004-12-01 |
HUP0300236A3 (en) | 2003-09-29 |
JP2001516343A (ja) | 2001-09-25 |
CA2281706A1 (en) | 1998-08-27 |
HUP0300236A2 (hu) | 2003-06-28 |
RU2199317C2 (ru) | 2003-02-27 |
CN1200701C (zh) | 2005-05-11 |
AU732903B2 (en) | 2001-05-03 |
DE69823548D1 (de) | 2004-06-03 |
CN1269718A (zh) | 2000-10-11 |
NZ337039A (en) | 2001-06-29 |
TR199902023T2 (xx) | 2001-09-21 |
ATE265207T1 (de) | 2004-05-15 |
DE69823548T2 (de) | 2005-02-24 |
NO994052D0 (no) | 1999-08-23 |
AU6176998A (en) | 1998-09-09 |
DK1039892T3 (da) | 2004-08-30 |
PL343902A1 (en) | 2001-09-10 |
NO994052L (no) | 1999-10-20 |
BR9807443A (pt) | 2000-04-25 |
CA2281706C (en) | 2008-08-05 |
US6306908B1 (en) | 2001-10-23 |
EP1039892A2 (en) | 2000-10-04 |
WO1998036745A3 (en) | 2002-10-03 |
IL131126A0 (en) | 2001-01-28 |
ID22744A (id) | 1999-12-09 |
HK1034033A1 (en) | 2001-10-12 |
PT1039892E (pt) | 2004-09-30 |
SK112399A3 (en) | 2000-12-11 |
TWI230607B (en) | 2005-04-11 |
EP1039892B1 (en) | 2004-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL131126A (en) | Compositions for reducing the incidence of necrotizing enterocolitis and the preparation thereof | |
Vidgren et al. | Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men | |
DK1121115T3 (da) | PUFA-tilskud | |
DE69622722D1 (de) | Fette enthaltende Ernährungszusammensetzung zur Behandlung des Stoffwechselssyndroms | |
PL190841B1 (pl) | Syntetyczna kompozycja lipidowa i jej zastosowanie do wytwarzania pokarmu dla niemowląt | |
EP2255668A3 (en) | Production and Use of a Polar Lipid-Rich Fraction Containing Omega-3 and/or Omega-6 Highly Unsaturated Fatty Acids from Microbes, Genetically Modified Plant Seeds and Marine Organisms | |
NZ331084A (en) | Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids | |
AU677318B2 (en) | A lipidic composition intended for use as a food or in food products | |
TW200744463A (en) | Nutritional supplement containing long-chain polyunsaturated fatty acids | |
KR940018091A (ko) | 불포화 지방산을 포함하는 처방 | |
CO5550401A2 (es) | Mezclas lipidas y productos alimenticios que contienen acido graso oleico y acidos grasos omega-6 diseñados para aumentar el nivel de lipido intramiocelular | |
DK1027831T3 (da) | Stabiliseret fedtstofsammensætning, fremgangsmåde til fremstilling deraf og ernæringsprodukt indeholdende denne | |
ATE454820T1 (de) | Neuartige fettpulver | |
Weber et al. | Lipids in infant formulas and human milk fat substitutes | |
Hassam | The influence of α-linolenic acid (18: 3ω3) on the metabolism of γ-linolenic acid (18: 3ω6) in the rat | |
OGUNLEIYE et al. | Effect of fish oil and safflower oil in common Japanese diet on human plasma fatty acid composition | |
Sandoval et al. | Omega-3 in the Prevention of Cardiovascular Diseases | |
Cha et al. | Effects of α-Linolenic, Eicosapentaenoic and Docosahexaenoic Acids on the Content and Fatty Acid Composition of Brain Phospholipid in Rats | |
Jiang | Studies on egg yolk lipids and ovo-cholesterol metabolism. | |
Nettleton | Omega-3 and Omega-6 Polyunsaturated Fatty Acids in the American Diet. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |